Kelly L Wyres1, Jane Hawkey2, Mirianne Mirčeta3, Louise M Judd2, Ryan R Wick2, Claire L Gorrie4, Nigel F Pratt5, Jill S Garlick5, Kerrie M Watson5, David V Pilcher6,7, Steve A McGloughlin6,7, Iain J Abbott8, Nenad Macesic2,8, Denis W Spelman8, Adam W J Jenney9,10, Kathryn E Holt2,11. 1. Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia. kelly.wyres@monash.edu. 2. Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia. 3. Microbiology Unit, Alfred Health, Melbourne, Victoria, Australia. 4. Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia. 5. Infectious Diseases Clinical Research Unit, The Alfred Hospital, Melbourne, Victoria, Australia. 6. Intensive Care Unit, The Alfred Hospital, Melbourne, Victoria, Australia. 7. Australian and New Zealand Intensive Care - Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. 8. Department of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia. 9. Microbiology Unit, Alfred Health, Melbourne, Victoria, Australia. a.jenney@alfred.org.au. 10. Department of Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia. a.jenney@alfred.org.au. 11. London School of Hygiene and Tropical Medicine, London, UK.
Abstract
BACKGROUND: Third-generation cephalosporin-resistant Gram-negatives (3GCR-GN) and vancomycin-resistant enterococci (VRE) are common causes of multi-drug resistant healthcare-associated infections, for which gut colonisation is considered a prerequisite. However, there remains a key knowledge gap about colonisation and infection dynamics in high-risk settings such as the intensive care unit (ICU), thus hampering infection prevention efforts. METHODS: We performed a three-month prospective genomic survey of infecting and gut-colonising 3GCR-GN and VRE among patients admitted to an Australian ICU. Bacteria were isolated from rectal swabs (n = 287 and n = 103 patients ≤2 and > 2 days from admission, respectively) and diagnostic clinical specimens between Dec 2013 and March 2014. Isolates were subjected to Illumina whole-genome sequencing (n = 127 3GCR-GN, n = 41 VRE). Multi-locus sequence types (STs) and antimicrobial resistance determinants were identified from de novo assemblies. Twenty-three isolates were selected for sequencing on the Oxford Nanopore MinION device to generate completed reference genomes (one for each ST isolated from ≥2 patients). Single nucleotide variants (SNVs) were identified by read mapping and variant calling against these references. RESULTS: Among 287 patients screened on admission, 17.4 and 8.4% were colonised by 3GCR-GN and VRE, respectively. Escherichia coli was the most common species (n = 36 episodes, 58.1%) and the most common cause of 3GCR-GN infection. Only two VRE infections were identified. The rate of infection among patients colonised with E. coli was low, but higher than those who were not colonised on admission (n = 2/33, 6% vs n = 4/254, 2%, respectively, p = 0.3). While few patients were colonised with 3GCR- Klebsiella pneumoniae or Pseudomonas aeruginosa on admission (n = 4), all such patients developed infections with the colonising strain. Genomic analyses revealed 10 putative nosocomial transmission clusters (≤20 SNVs for 3GCR-GN, ≤3 SNVs for VRE): four VRE, six 3GCR-GN, with epidemiologically linked clusters accounting for 21 and 6% of episodes, respectively (OR 4.3, p = 0.02). CONCLUSIONS: 3GCR-E. coli and VRE were the most common gut colonisers. E. coli was the most common cause of 3GCR-GN infection, but other 3GCR-GN species showed greater risk for infection in colonised patients. Larger studies are warranted to elucidate the relative risks of different colonisers and guide the use of screening in ICU infection control.
BACKGROUND: Third-generation cephalosporin-resistant Gram-negatives (3GCR-GN) and vancomycin-resistant enterococci (VRE) are common causes of multi-drug resistant healthcare-associated infections, for which gut colonisation is considered a prerequisite. However, there remains a key knowledge gap about colonisation and infection dynamics in high-risk settings such as the intensive care unit (ICU), thus hampering infection prevention efforts. METHODS: We performed a three-month prospective genomic survey of infecting and gut-colonising 3GCR-GN and VRE among patients admitted to an Australian ICU. Bacteria were isolated from rectal swabs (n = 287 and n = 103 patients ≤2 and > 2 days from admission, respectively) and diagnostic clinical specimens between Dec 2013 and March 2014. Isolates were subjected to Illumina whole-genome sequencing (n = 127 3GCR-GN, n = 41 VRE). Multi-locus sequence types (STs) and antimicrobial resistance determinants were identified from de novo assemblies. Twenty-three isolates were selected for sequencing on the Oxford Nanopore MinION device to generate completed reference genomes (one for each ST isolated from ≥2 patients). Single nucleotide variants (SNVs) were identified by read mapping and variant calling against these references. RESULTS: Among 287 patients screened on admission, 17.4 and 8.4% were colonised by 3GCR-GN and VRE, respectively. Escherichia coli was the most common species (n = 36 episodes, 58.1%) and the most common cause of 3GCR-GNinfection. Only two VRE infections were identified. The rate of infection among patients colonised with E. coli was low, but higher than those who were not colonised on admission (n = 2/33, 6% vs n = 4/254, 2%, respectively, p = 0.3). While few patients were colonised with 3GCR- Klebsiella pneumoniae or Pseudomonas aeruginosa on admission (n = 4), all such patients developed infections with the colonising strain. Genomic analyses revealed 10 putative nosocomial transmission clusters (≤20 SNVs for 3GCR-GN, ≤3 SNVs for VRE): four VRE, six 3GCR-GN, with epidemiologically linked clusters accounting for 21 and 6% of episodes, respectively (OR 4.3, p = 0.02). CONCLUSIONS: 3GCR-E. coli and VRE were the most common gut colonisers. E. coli was the most common cause of 3GCR-GNinfection, but other 3GCR-GN species showed greater risk for infection in colonised patients. Larger studies are warranted to elucidate the relative risks of different colonisers and guide the use of screening in ICU infection control.
Authors: Robyn S Lee; Benjamin P Howden; M Lindsay Grayson; Norelle L Sherry; Claire L Gorrie; Jason C Kwong; Rhonda L Stuart; Tony M Korman; Caroline Marshall; Charlie Higgs; Hiu Tat Chan; Maryza Graham; Paul D R Johnson; Marcel J Leroi; Caroline Reed; Michael J Richards; Monica A Slavin; Leon J Worth Journal: Infect Control Hosp Epidemiol Date: 2020-11-26 Impact factor: 3.254
Authors: Daniel E Freedberg; Margaret J Zhou; Margot E Cohen; Medini K Annavajhala; Sabrina Khan; Dagmara I Moscoso; Christian Brooks; Susan Whittier; David H Chong; Anne-Catrin Uhlemann; Julian A Abrams Journal: Intensive Care Med Date: 2018-06-23 Impact factor: 17.440
Authors: Claire L Gorrie; Mirjana Mirceta; Ryan R Wick; David J Edwards; Nicholas R Thomson; Richard A Strugnell; Nigel F Pratt; Jill S Garlick; Kerri M Watson; David V Pilcher; Steve A McGloughlin; Denis W Spelman; Adam W J Jenney; Kathryn E Holt Journal: Clin Infect Dis Date: 2017-07-15 Impact factor: 9.079
Authors: Philip L Russo; Andrew J Stewardson; Allen C Cheng; Tracey Bucknall; Brett G Mitchell Journal: Antimicrob Resist Infect Control Date: 2019-07-15 Impact factor: 4.887
Authors: Alessandro Cassini; Diamantis Plachouras; Tim Eckmanns; Muna Abu Sin; Hans-Peter Blank; Tanja Ducomble; Sebastian Haller; Thomas Harder; Anja Klingeberg; Madlen Sixtensson; Edward Velasco; Bettina Weiß; Piotr Kramarz; Dominique L Monnet; Mirjam E Kretzschmar; Carl Suetens Journal: PLoS Med Date: 2016-10-18 Impact factor: 11.069
Authors: Tanya Gurieva; Mirjam J D Dautzenberg; Marek Gniadkowski; Lennie P G Derde; Marc J M Bonten; Martin C J Bootsma Journal: Clin Infect Dis Date: 2018-02-01 Impact factor: 9.079
Authors: Sam Lipworth; Karina-Doris Vihta; Tim Davies; Sarah Wright; Merline Tabirao; Kevin Chau; Alison Vaughan; James Kavanagh; Leanne Barker; Sophie George; Shelley Segal; Stephane Paulus; Lucinda Barrett; Sarah Oakley; Katie Jeffery; Lisa Butcher; Tim Peto; Derrick Crook; Sarah Walker; Seilesh Kadambari; Nicole Stoesser Journal: Commun Med (Lond) Date: 2022-08-11
Authors: Jane Hawkey; Kelly L Wyres; Louise M Judd; Taylor Harshegyi; Luke Blakeway; Ryan R Wick; Adam W J Jenney; Kathryn E Holt Journal: Genome Med Date: 2022-08-23 Impact factor: 15.266